London, England, 16 January, 2007 - SkyePharma PLC (LSE: SKP; NASDAQ: SKYE) announces that, further to its announcement on 9 January 2007, a Circular, which details the proposed disposal of its Injectable Business and the proposed placing with certain institutional investors, will today be posted to shareholders of the Company.
